ANIX - Anixa Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
10/30/2018
10/30/2017
10/30/2016
Total Revenue
250
1,113
363
300
Cost of Revenue
167
768
105
217
Gross Profit
83
344
258
83
Operating Expenses
Research Development
7,035
6,813
1,598
1,556
Selling General and Administrative
6,715
6,912
4,411
2,710
Total Operating Expenses
14,250
14,050
6,334
4,592
Operating Income or Loss
-14,167
-13,706
-6,076
-4,509
Interest Expense
-
0
500
520
Total Other Income/Expenses Net
-
-583
1,548
-106
Income Before Tax
-15,099
-14,243
-5,009
-5,016
Income Tax Expense
0
0
0
0
Income from Continuing Operations
-15,099
-14,243
-5,009
-5,016
Net Income
-14,862
-13,996
-5,009
-5,016
Net Income available to common shareholders
-14,862
-13,996
-7,018
-5,016
Reported EPS
Basic
-
-0.79
-0.58
-0.52
Diluted
-
-0.79
-0.58
-0.52
Weighted average shares outstanding
Basic
-
17,624
12,197
9,602
Diluted
-
17,624
12,197
9,602
EBITDA
-
-13,899
-4,140
-4,138